AbCellera Biologics Inc. Balance Sheet
ABCL / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
AbCellera Biologics Inc. had $1.4B in total assets and $967M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $128.5M | $156.3M | $133.3M | $386.5M | $476.1M | $594.1M | - |
| Inventory | $6.3M | - | - | - | - | - | - |
| Current Assets | $728.2M | $751.4M | $872.0M | $1.0B | $929.8M | $813.3M | - |
| PP&E (Net) | - | - | - | $217.3M | $111.6M | $17.9M | - |
| Goodwill | $47.8M | $47.8M | $47.8M | $47.8M | $31.5M | $31.5M | - |
| Total Assets | $1.4B | $1.4B | $1.5B | $1.5B | $1.3B | $1.0B | - |
| Current Liabilities | $64.3M | $76.6M | $119.0M | $118.3M | $120.7M | $103.5M | - |
| Shareholders' Equity | $966.9M | $1.1B | $1.2B | $1.2B | $10.3M | $830.5M | $10.3M |